Smith & Nephew

1D
1W
1M
3M
YTD
1Y
5Y
ALL

Why Robinhood?

Robinhood gives you the tools you need to put your money in motion. You can buy or sell Smith & Nephew and other ETFs, options, and stocks.

About SNN

Smith & Nephew plc engages in the development, manufacture, marketing, and sale of medical devices. It operates through the following segments: Orthopaedics, Sports Medicine and ENT, and Advanced Wound Management. 

CEO
Deepak S Nath
CEODeepak S Nath
Employees
18,456
Employees18,456
Headquarters
Watford, Herefordshire
HeadquartersWatford, Herefordshire
Founded
1856
Founded1856
Employees
18,456
Employees18,456

SNN Key Statistics

Market cap
14.04B
Market cap14.04B
Price-Earnings ratio
28.92
Price-Earnings ratio28.92
Dividend yield
2.24%
Dividend yield2.24%
Average volume
739.45K
Average volume739.45K
High today
$32.88
High today$32.88
Low today
$32.60
Low today$32.60
Open price
$32.77
Open price$32.77
Volume
558.08K
Volume558.08K
52 Week high
$38.79
52 Week high$38.79
52 Week low
$23.69
52 Week low$23.69

Stock Snapshot

As of today, Smith & Nephew(SNN) shares are valued at $32.70. The company's market cap stands at 14.04B, with a P/E ratio of 28.92 and a dividend yield of 2.2%.

On 2025-11-15, Smith & Nephew(SNN) stock moved within a range of $32.60 to $32.88. With shares now at $32.70, the stock is trading +0.3% above its intraday low and -0.5% below the session's peak.

Trading volume for Smith & Nephew(SNN) stock has reached 558.08K, versus its average volume of 739.45K.

Over the past 52 weeks, Smith & Nephew(SNN) stock has traded between a high of $38.79 and a low of $23.69.

Over the past 52 weeks, Smith & Nephew(SNN) stock has traded between a high of $38.79 and a low of $23.69.

SNN News

TipRanks 3d
Smith & Nephew Announces Vesting of CEO’s Restricted Shares

Meet Your ETF AI Analyst Discover how TipRanks' ETF AI Analyst can help you make smarter investment decisions AI Analyst can help you make smarter investment...

TipRanks 4d
Smith & Nephew price target lowered to $34 from $36 at Canaccord

Canaccord lowered the firm’s price target on Smith & Nephew to $34 from $36 and keeps a Hold rating on the shares. The firm updated its model followong Q3 resul...

Nasdaq 7d
JP Morgan Cazenove Reiterates Smith & Nephew Overweight Recommendation

Fintel reports that on November 7, 2025, JP Morgan Cazenove reiterated coverage of Smith & Nephew (OTCPK:SNNUF) with a Overweight recommendation. Analyst Price...

JP Morgan Cazenove Reiterates Smith & Nephew Overweight Recommendation

Analyst ratings

61%

of 18 ratings
Buy
38.9%
Hold
61.1%
Sell
0%
All investments involve risks, including the loss of principal. Securities trading offered through Robinhood Financial LLC, Member SIPC and a registered broker-dealer.